Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing
28 nov. 2023 07h42 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health...
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
07 nov. 2023 08h55 HE
|
PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing
02 nov. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
Addressing the $250 Billion Excess Inventory Issue with New Course on Supplier Management
25 oct. 2023 06h48 HE
|
Research and Markets
Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In the wake of a 2023 Kearney study highlighting the stark reality of a $250+ billion problem of excess inventory in the U.S., brought sharply into focus by...
Mastering cGMP Compliance: A Comprehensive Seminar on Good Manufacturing Practices and FDA Inspections (December 11-13, 2023)
18 oct. 2023 08h33 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Annual GMP Master Class 2023" training has been added to ResearchAndMarkets.com's offering. cGMPs or Current Good Manufacturing Practices is a...
Vantage Hemp Co. Concludes Audit with Australia’s Therapeutic Goods Administration
21 sept. 2023 07h00 HE
|
Vantage Hemp
Greeley, Colorado, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods...
Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
07 sept. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
01 sept. 2023 02h00 HE
|
SOMAÍ Pharmaceuticals
LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical cannabis product manufacturer, is pleased to...
Quality and GMP Compliance For Virtual Companies Seminar: Navigating GMP Challenges - Virtual Pharma's Pathway to Growth
17 août 2023 08h53 HE
|
Research and Markets
Dublin, Aug. 17, 2023 (GLOBE NEWSWIRE) -- The "Quality and GMP Compliance For Virtual Companies - New Perspective For Professionals" training has been added to ResearchAndMarkets.com's offering. ...
An Introduction to ISO 22716: Cosmetic Products GMP (Good Manufacturing Practice) Training Course
02 août 2023 04h58 HE
|
Research and Markets
Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "An Introduction to ISO 22716 - GMP (Good Manufacturing Practice) for Cosmetic Products Training Course" conference has been added to ...